表紙
市場調査レポート

CRO (医薬品開発受託機関) の市場:世界における各種契約と事業運営戦略

Contract Research Organization Market - Global Deals and Operational Strategies

発行 CBR Pharma Insights 商品コード 334085
出版日 ページ情報 英文 77 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
CRO (医薬品開発受託機関) の市場:世界における各種契約と事業運営戦略 Contract Research Organization Market - Global Deals and Operational Strategies
出版日: 2015年06月01日 ページ情報: 英文 77 Pages
概要

当レポートでは、CRO (医薬品開発受託機関) による過去数年の契約動向および事業運営戦略について調査し、アウトソーシングの理由とアウトソーシングサービスモデルの概要、CROによる事業運営戦略の例、世界の各種契約動向、大型の買収・提携契約、地域別の契約動向、主要CROの財務動向の比較、SWOT分析、プロファイルなどをまとめています。

目次

  • エグゼクティブサマリー
  • イントロダクション
  • 市場力学
    • 事業運営モデル
    • 事業運営戦略の例
    • 世界の契約分析
  • 協力・買収
    • 主な買収
    • 主な提携
  • 地域分析
    • 北米
      • 契約分析
      • サービスデリバリー・事業運営戦略
      • 提携
      • 収益・成長のリーダー
    • 欧州
      • 契約分析
      • サービスデリバリー・事業運営戦略
      • 提携
      • 収益・成長のリーダー
    • アジア太平洋
      • 契約分析
      • サービスデリバリー・事業運営戦略
      • 提携
      • 収益・成長のリーダー
    • 新興市場
      • 市場評価
      • 買収
  • 企業業績
    • 企業の稼動・資本管理動向
    • 企業のベンチマーキング
    • 企業の位置付け
  • 企業プロファイル・SWOT分析
  • 付録
目次
Product Code: GBI058CBR

Summary

GBI Research's latest report, "Contract Research Organization Market - Global Deals and Operational Strategies" discusses the deal making activity during the past five years and in-depth analysis of the key deals involving more than 40 public and privately held CROs. The operational strategies adopted by key players in the recent years have been listed. A heatmap analysis of the key companies was done based on their firm utilization and capital management. SWOT analysis and profiles are given for the key companies in the market.

Companies mentioned in the report are Quintiles, Covance, Parexel, Catalent, ICON, PRA Health, Charles River, INC Research, WuXi PharmaTech, CMIC Holdings, EPS Corporation, Recipharm, Novotech, Laboratory Corporation of America Holdings, Consort Medical, Meiji Seika, Eurofins Scientific, Simbec Research, Hangzhou Tigermed, MPI Research, Sun Pharma, Noble Life Sciences, Chiltern International, BioPharma, Carlina, Euprotech, Protagen, Assign, Aurigon, Celonic and PharmaLex, Cromos Pharma, Avillion, Pfizer, Sanofi, Harlan Labs, Almac Group, Jubilant Biosys

Scope

The scope of the report includes -

  • Overview of key reasons behind outsourcing, outsourcing service models
  • Examples of operational strategies
  • Global deals analysis by type and value
  • Major acquisitions and partnerships
  • Regional analysis of North America, Europe, Asia-Pacific and Emerging markets
  • Company benchmarking based on heatmap analysis
  • Vendor positioning
  • SWOT analysis and profiles of key players

Key Reasons to Purchase

The report will enhance your decision-making capability by allowing you to -

  • Identify the top players in the CRO market, financial revenues and key services offered
  • Analyze the key geographies that are lucrative markets for deal making, market-entry and market expansion strategies
  • Analyze the trends in acquisitions, licensing and other type of deals and explore potential investment opportunities
  • Understand the operational strategies of key players

Table of Contents

  • Executive Summary
  • Introduction
  • Market Dynamics
    • Operating Models
    • Examples of Operational Strategies
    • Global Deal Analysis
  • Collaborations and Acquisitions
    • Major Acquisitions
    • Major Partnerships
  • Regional Analysis
    • North America
      • Deal Analysis
      • Service Delivery and Operational
      • Strategies
      • Partnerships
      • Revenue and Growth Leaders
    • Europe
      • Deal Analysis
      • Service Delivery and Operational
      • Strategies
      • Partnerships
      • Revenue and Growth Leaders
    • Asia-Pacific
      • Deal Analysis
      • Service Delivery and Operational
      • Strategies
      • Partnerships
      • Revenue and Growth Leaders
    • Emerging Markets
      • Market Assessment
      • Acquisitions
  • Firm Utilization
    • Firm Utilization and Capital Management
    • Company Benchmarking
    • Vendor Positioning
  • Profiles and SWOT Analysis
  • Appendix
Back to Top